 Inflammatory Bowel Diseases
"Inflammatory Bowel Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Descriptor ID |
D015212
|
| MeSH Number(s) |
C06.405.205.731 C06.405.469.432
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Bowel Diseases".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Bowel Diseases".
This graph shows the total number of publications written about "Inflammatory Bowel Diseases" by people in this website by year, and whether "Inflammatory Bowel Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 1 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 0 | 2 | 2 | | 2002 | 0 | 2 | 2 | | 2003 | 0 | 2 | 2 | | 2004 | 3 | 2 | 5 | | 2005 | 2 | 0 | 2 | | 2006 | 2 | 1 | 3 | | 2007 | 4 | 0 | 4 | | 2008 | 3 | 1 | 4 | | 2009 | 0 | 1 | 1 | | 2010 | 4 | 0 | 4 | | 2011 | 4 | 3 | 7 | | 2012 | 4 | 2 | 6 | | 2013 | 10 | 2 | 12 | | 2014 | 8 | 1 | 9 | | 2015 | 7 | 1 | 8 | | 2016 | 7 | 7 | 14 | | 2017 | 19 | 2 | 21 | | 2018 | 18 | 4 | 22 | | 2019 | 17 | 3 | 20 | | 2020 | 13 | 2 | 15 | | 2021 | 25 | 1 | 26 | | 2022 | 21 | 1 | 22 | | 2023 | 22 | 0 | 22 | | 2024 | 10 | 4 | 14 | | 2025 | 11 | 1 | 12 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Inflammatory Bowel Diseases" by people in Profiles.
-
Gross SA, Shaukat A, Afzali A, Ahn JC, Bajaj JS, Barkin JA, Bilal M, Chawla S, Coelho-Prabhu N, Enslin SM, Feld AD, Gagneja HK, Hass DJ, Hernandez-Barco YG, Horst SN, Jacobson BC, Jones PD, Kaul V, Kushnir VM, Leggett CL, Leung G, Mascarenhas M, Parasa S, Parsa N, Schairer JN, Shah ED, Simonetto DA, Spiegel B, Stidham RW, Suthrum P, Thomas S, Phillips ME. Artificial Intelligence for Gastroenterology Practice: A Modified Delphi Consensus. Am J Gastroenterol. 2026 Apr 01; 121(4):1017-1024.
-
Haydek JP, Mohan R, Lew J, Oonk A, Cheng D, Ahmed W, Click B, Fennimore B, Gerich M, Patel SG, Wani S, Hou JK, Scott FI. Treat-to-Target Monitoring Adherence and Rates of Healthcare Utilization in Patients With Inflammatory Bowel Disease in a Regional Healthcare System. Clin Transl Gastroenterol. 2026 Jan 01; 17(1):e00942.
-
Alula KM, Nguyen TT, de Zoeten EF. Regulation of intestinal regulatory T cells via stress response pathways in inflammatory bowel disease. Autoimmunity. 2026 Dec 31; 59(1):2602715.
-
Hazime H, Ducasa GM, Santander AM, Brito N, Gonzalez-Horta EE, Quintero MA, Barnes S, Wilson L, Zhang Y, Yu F, Gharaibeh RZ, Jobin C, Faust KM, Damas OM, Deshpande A, Kerman DH, Proksell S, Pignac-Kobinger J, Fernández I, Burgueño JF, Abreu MT. DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis. Gut. 2025 Sep 08; 74(10):1589-1601.
-
Smolen J, Sands BE, Jackson DJ, Wechsler ME, Jackson DJ, Akuthota P, Lega Hoyte FC, Pavord I, Katial RK, Rogers L. Asthma remission in the context of other immune-mediated diseases. J Allergy Clin Immunol. 2025 Sep; 156(3S):S1-S6.
-
Olson J, Beaulieu D, Bennett A, Dalal R, Pabla B, Schwartz DA, Scoville E, McCoy A, Horst S. Telecare enhances the retention of patients with inflammatory bowel disease within a tertiary care inflammatory bowel disease center. J Telemed Telecare. 2026 May; 32(4):359-364.
-
Bennett A, Field J, Newman KL, Click B, Pothula S, Horst S, Davison J, Lin A, Chedid V. Gender-Affirming Hormone Therapy and Risk of Inflammatory Bowel Disease Flare in Transgender and Gender Diverse Adults. Am J Gastroenterol. 2026 Feb 01; 121(2):404-409.
-
Yu Z, Swift KA, Hedges MA, Theiss AL, Andres SF. Microscopic messengers: Extracellular vesicles shaping gastrointestinal health and disease. Physiol Rep. 2025 Apr; 13(7):e70292.
-
Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar MC, Rubin DT, Hashash JG, Metwally M, Ali T, Ma C, Hoentjen F, Narula N, Bessissow T, Rosenfeld G, McCurdy JD, Ananthakrishnan AN, Cross RK, Rodriguez Gaytan JR, Gurrola ES, Patel S, Siegel CA, Melmed GY, Weaver SA, Power S, Zou G, Jairath V, Hou JK. Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ Open Gastroenterol. 2025 Mar 31; 12(1).
-
Malik S, Naqvi SAA, Shadali AH, Khan H, Christof M, Niu C, Schwartz DA, Adler DG. Fecal Microbiota Transplantation (FMT) and Clinical Outcomes Among Inflammatory Bowel Disease (IBD) Patients: An Umbrella Review. Dig Dis Sci. 2025 May; 70(5):1873-1896.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|